{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:01:32Z","timestamp":1712109692366},"reference-count":55,"publisher":"American Society of Consultant Pharmacists","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.4140\/tcp.n.2004.725","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T02:05:00Z","timestamp":1294884300000},"page":"725-735","source":"Crossref","is-referenced-by-count":0,"title":["Should Postmenopausal Hormone Therapy Be Used to Prevent Osteoporosis?"],"prefix":"10.4140","volume":"19","author":[{"given":"Brigitte L.","family":"Sicat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0749-0690(02)00022-8","article-title":"Osteoporosis in elderly: prevention and treatment","volume":"18","author":"M Srivastava","year":"2002","journal-title":"Clin Geriatr Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s001980050129","article-title":"The prevalence of osteoporosis in nursing home residents","volume":"9","author":"S Zimmerman","year":"1999","journal-title":"Osteoporos Int"},{"key":"3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"4","unstructured":"National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis (http:\/\/www.nof.org\/physguide\/table_of_contents.htm). <a target=\"_blank\" href='http:\/\/www.nof.org\/physguide\/table_of_contents.htm)'>http:\/\/www.nof.org\/physguide\/table_of_contents.htm)<\/a>"},{"key":"5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM198011203032102","article-title":"Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen","volume":"303","author":"N Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","article-title":"Estrogen replacement therapy and fractures in older women","volume":"122","author":"J Cauley","year":"1995","journal-title":"Ann Intern Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures. A meta-analysis of randomized trials","volume":"285","author":"D Torgerson","year":"2001","journal-title":"JAMA"},{"key":"8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"M Stampfer","year":"1991","journal-title":"Prev Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"D Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study","volume":"325","author":"M Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"for the Heart and Estrogen\/progestin Replacement Study (HERS) research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"S Hulley","year":"1998","journal-title":"JAMA"},{"key":"13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"D Grady","year":"2002","journal-title":"JAMA"},{"key":"14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"C Viscoli","year":"2001","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jbmr.5650101014","article-title":"Effect of menopause on femoral and vertebral bone loss","volume":"10","author":"J Pouilles","year":"1995","journal-title":"J Bone Miner Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/B978-012098652-1.50139-6","article-title":"Estrogens and progestins","volume-title":"Principles of Bone Biology","author":"D Rickard","year":"2002"},{"key":"17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.276.17.1389","article-title":"Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.286.7.815","article-title":"Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial","volume":"286","author":"D Villareal","year":"2001","journal-title":"JAMA"},{"key":"19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.277.7.543","article-title":"Timing of postmenopausal estrogen for optimal bone mineral density","volume":"277","author":"D Schneider","year":"1997","journal-title":"JAMA"},{"key":"20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-130-11-199906010-00005","article-title":"The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women","volume":"130","author":"R Recker","year":"1999","journal-title":"Ann Intern Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.287.20.2668","article-title":"Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women","volume":"287","author":"R Lindsay","year":"2002","journal-title":"JAMA"},{"key":"22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM198011203032102","article-title":"Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen","volume":"303","author":"N Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures","volume":"285","author":"D Torgerson","year":"2001","journal-title":"JAMA"},{"key":"24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative","volume":"290","author":"J Cauley","year":"2003","journal-title":"JAMA"},{"key":"25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","article-title":"Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease","volume":"348","author":"M Tang","year":"1996","journal-title":"Lancet"},{"key":"27","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study","volume":"288","author":"P Zandi","year":"2002","journal-title":"JAMA"},{"key":"28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study","volume":"283","author":"R Mulnard","year":"2000","journal-title":"JAMA"},{"key":"29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.54.2.295","article-title":"Estrogen for Alzheimer's disease in women: randomized, double-blind, placebocontrolled trial","volume":"54","author":"V Henderson","year":"2000","journal-title":"Neurology"},{"key":"30","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The women's health initiative memory study: randomized controlled trial","volume":"289","author":"S Shumaker","year":"2003","journal-title":"JAMA"},{"key":"31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-137-10-200211190-00013","article-title":"U.S. Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200310010-00003","article-title":"Amended report from the North American Menopause Society Advisory Panel on Postmenopausal Hormone Therapy","volume":"10","year":"2003","journal-title":"Menopause"},{"key":"33","unstructured":"The American College of Obstetricians and Gynecologists. Statement of the American College of Obstetricians and Gynecologists on Hormone Therapy for the Prevention and Treatment of Postmenopausal Osteoporosis for the FDA Endocrinologic and Metabolic Drugs Advisory Committee. http:\/\/www.acog.org\/from_home\/publications\/press_releases\/nr10-07-03.cfm. <a target=\"_blank\" href='http:\/\/www.acog.org\/from_home\/publications\/press_releases\/nr10-07-03.cfm'>http:\/\/www.acog.org\/from_home\/publications\/press_releases\/nr10-07-03.cfm<\/a>"},{"key":"34","unstructured":"U.S. Food and Drug Administration. FDA News: FDA approves new labels for estrogen and estrogen with progestin therapies for postmenopausal women following review of Women's Health Initiative data. Available at: http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2003\/NEW00863.html. <a target=\"_blank\" href='http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2003\/NEW00863.html'>http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2003\/NEW00863.html<\/a>"},{"key":"35","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.85.12.4462","article-title":"The effect of low-dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study","volume":"85","author":"K Prestwood","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5122(01)00257-2","article-title":"The effect of low-dose conjugated equine estrogens and cyclic MPA on bone density","volume":"41","author":"M Gass","year":"2002","journal-title":"Maturitas"},{"key":"37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.7326\/0003-4819-136-10-200205210-00009","article-title":"Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities","volume":"136","author":"S Greenspan","year":"2002","journal-title":"Ann Intern Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a three-year randomized clinical trial","volume":"282","author":"B Ettinger","year":"1999","journal-title":"JAMA"},{"key":"39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE randomized trial","volume":"287","author":"E Barrett-Connor","year":"2002","journal-title":"JAMA"},{"key":"40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S8756-3282(01)00706-2","article-title":"Effect of one-year of discontinuation of raloxifene or estrogen therapy on bone mineral density after five years of treatment in healthy postmenopausal women","volume":"30","author":"S Neele","year":"2002","journal-title":"Bone"},{"key":"41","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone mineral density and bone markers","volume":"87","author":"J Gallagher","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"42","unstructured":"The American Association of Clinical Endocrinologists. AACE Medical Guidelines for Clinical Practice: 2001 Postmenopausal Osteoporosis - Revised 2003. Available at: http:\/\/www.aace.com\/clin\/guidelines\/. <a target=\"_blank\" href='http:\/\/www.aace.com\/clin\/guidelines\/'>http:\/\/www.aace.com\/clin\/guidelines\/<\/a>"},{"key":"43","unstructured":"Medicare. Your Medicare Coverage. Available at http:\/\/www.medicare.gov. <a target=\"_blank\" href='http:\/\/www.medicare.gov'>http:\/\/www.medicare.gov<\/a>"},{"key":"44","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1001\/jama.287.16.2130","article-title":"A 60-year old woman trying to discontinue hormone replacement therapy","volume":"287","author":"D Grady","year":"2002","journal-title":"JAMA"},{"key":"45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(00)00289-8","article-title":"Management of hot flashes in breast-cancer survivors","volume":"2","author":"C Loprinzi","year":"2001","journal-title":"Lancet Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/77.11.1207","article-title":"Pathophysiology and treatment of hot flashes","volume":"77","author":"T Shanafelt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"R Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"48","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial","volume":"356","author":"C Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9378(87)90050-0","article-title":"Treatment of menopausal hot flashes with transdermal administration of clonidine","volume":"156","author":"M Nagamani","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"50","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes","volume":"289","author":"V Stearns","year":"2003","journal-title":"JAMA"},{"key":"51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials","volume":"137","author":"F Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"52","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in the elderly women","volume":"23","author":"M Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"B Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"key":"54","first-page":"71","article-title":"Institute of Medicine. Calcium","volume-title":"Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride","year":"1997"},{"key":"55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0749-0690(02)00073-3","article-title":"Calcium, vitamin D, and nutrition in elderly adults","volume":"19","author":"J Nieves","year":"2003","journal-title":"Clin Geriatr Med"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:15:23Z","timestamp":1712103323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2004\/00000019\/00000008\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8,1]]}},"alternative-id":["R12T148117U61T54"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2004.725","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8,1]]}}}